These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4797781)

  • 1. Determination of HL-A2 gene dosage effect of lymphocytes by release of radioactive chromium.
    White AG; Da Costa AJ; Darg C
    Tissue Antigens; 1973; 3(2):123-9. PubMed ID: 4797781
    [No Abstract]   [Full Text] [Related]  

  • 2. The serologic detection of HL-A antigens in human milk.
    Dawson JR; Shasby SS; Amos DB
    Tissue Antigens; 1974; 4(1):76-82. PubMed ID: 4858061
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of lymphocyte-dependent antibody in sera from multiply transfused patients.
    Yust I; Wunderlich JR; Mann DL; Terry WD
    Transplantation; 1974 Aug; 18(2):99-107. PubMed ID: 4211029
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-2-microglobulin. Part of the HL-A molecule in the cell membrane.
    Solheim BG; Thorsby E
    Tissue Antigens; 1974; 4(1):83-94. PubMed ID: 4134844
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of anti-W24 xenoantisera in rabbits.
    Ferrone S; Pellegrino MA; Billing R; Terasaki PI; Reisfeld RA
    Tissue Antigens; 1975 Feb; 5(1):41-7. PubMed ID: 1138440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The zygosity of HL-A antigens on lymphocytes determined by the rate of release of radioactive chromium.
    White AG; Da Costa AJ; Darg C
    Br J Haematol; 1973 Aug; 25(2):282. PubMed ID: 4726916
    [No Abstract]   [Full Text] [Related]  

  • 7. A new HL-A antigen at the LA locus positively associated with the W14 (MaKi) specificity of the FOUR locus.
    Ferrara GB; Tosi RM; Azzolina G; Carminati G
    Tissue Antigens; 1973; 3(2):130-5. PubMed ID: 4129463
    [No Abstract]   [Full Text] [Related]  

  • 8. A sensitive method for detecting antibodies in human sera used for tissue typing.
    Zighelboim J; Thiene T; Gale RP; Ossorio C; Fahey JL
    Transplantation; 1974 Aug; 18(2):180-5. PubMed ID: 4844241
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-dependent lymphocyte-mediated cytotoxicity in an allogeneic human system. II. Evidence for HL-A specificity.
    Dickmeiss E; Nielsen LS
    Scand J Immunol; 1974; 3(2):199-207. PubMed ID: 4822686
    [No Abstract]   [Full Text] [Related]  

  • 10. Rate of desensitization to HL-A antibodies in phytohaemagglutinin (PHA) stimulated lymphocytes.
    Rugarli C; Scorza R; Sabbadini MG
    Boll Ist Sieroter Milan; 1974; 53(4):573-7. PubMed ID: 4476215
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and characterization of HL-A variants in cultured human lymphoid cells.
    Pious D; Hawley P; Forrest G
    Proc Natl Acad Sci U S A; 1973 May; 70(5):1397-400. PubMed ID: 4514309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of histocompatibility (HL-A) antibodies and complement with synchronized human lymphoid cells in continuous culture.
    Ferrone S; Cooper NR; Pellegrino MA; Reisfeld RA
    J Exp Med; 1973 Jan; 137(1):55-68. PubMed ID: 4734592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit anti-HL-A2 sera.
    Robb RJ; Humphreys RE; Strominger JL
    Transplantation; 1975 May; 19(5):445-7. PubMed ID: 50659
    [No Abstract]   [Full Text] [Related]  

  • 14. Fate of HL-A antigens and antibodies at the lymphocyte surface.
    Cullen SE; Bernoco D; Carbonara AO; Jacot-Guillarmod H; Trinchieri G; Ceppellini R
    Transplant Proc; 1973 Dec; 5(4):1835-47. PubMed ID: 4130085
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of complement in the HL-A antibody-mediated lysis of lymphocytes.
    Ferrone S; Cooper NR; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1974 Mar; 6(1):13-9. PubMed ID: 4856285
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic analysis and biological properties of products of the third SD (AJ) locus of the HL-A region.
    Mayr WR; Bernoco D; De Marchi M; Ceppellini R
    Transplant Proc; 1973 Dec; 5(4):1581-93. PubMed ID: 4130068
    [No Abstract]   [Full Text] [Related]  

  • 17. The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase.
    Reisner EG; Amos DB
    Transplantation; 1972 Oct; 14(4):455-61. PubMed ID: 4404957
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross reactions of HL-A antibodies. I. Characterization by absorption and elution.
    Yunis EJ; Amos DB; Eguro SY; Dorf ME
    Transplantation; 1972 Oct; 14(4):474-9. PubMed ID: 4566162
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific cytolytic activity of lymphocytes: effect of antibodies against complement components C2, C3, and C5.
    Henney CS; Mayer MM
    Cell Immunol; 1971 Dec; 2(6):702-5. PubMed ID: 5005914
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity of heterologous antisera to components solubilized from rat thymocyte membranes.
    Eshhar Z
    Eur J Immunol; 1973 Nov; 3(11):668-73. PubMed ID: 4589167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.